Inflammatory Cytokines and the Risk of Cardiovascular Complications in Type 2 Diabetes

Table 3

The ratios of Treg (CD4+CD25+FOXP3) cells to Th17 or Th1 in type 2 diabetes patients.

Ratios	All type 2 diabetes (AD); (𝑛=40)	Diabetes with CHD; (𝑛=16)	Diabetes without CHD; (𝑛=24)	Healthy control subjects; (𝑛=30)
Treg/Th1 cells	0.351±0.1^∗	0.313±0.1^∗	0.131±0.05^∗∗Ψ	0.638±0.08
Treg/Th17 cells	0.302±0.04^∗∗	0.354±0.05^∗∗	0.26±0.03^∗∗∗Ψ	0.654±0.09

 ^∗𝑃<0.05, ^∗∗𝑃<0.01, and ^∗∗∗𝑃<0.001 versus healthy control subjects.
 ^Ψ𝑃<0.05 versus diabetes without CHD.